Literature DB >> 22703532

Low doses of fludrocortisone and hydrocortisone, alone or in combination, on vascular responsiveness to phenylephrine in healthy volunteers.

Bruno Laviolle1, Erwan Donal, Pascale Le Maguet, Fabrice Lainé, Eric Bellissant.   

Abstract

AIMS: A single administration of hydrocortisone has been shown to enhance the pressor response to phenylephrine in healthy volunteers and to norepinephrine in septic shock patients. Similar data do not exist for fludrocortisone. Since there continues to be disagreement about the utility of fludrocortisone in septic shock, we assessed the effects of a single administration of low doses of hydrocortisone (50 mg intravenously) and fludrocortisone (50 μg orally), given either alone or in combination, on phenylephrine mean arterial pressure and cardiac systolic and diastolic function dose-response relationships in 12 healthy male volunteers with hypo-aldosteronism induced by intravenous sodium loading.
METHODS: This was a placebo-controlled, randomized, double-blind, crossover study performed according to a 2 × 2 factorial design. Subjects received first a 2000 ml infusion of NaCl 0.9% during 2 h. Then fludrocortisone 50 μg (or its placebo) was administered orally and hydrocortisone 50 mg (or its placebo) was injected intravenously. At 1.5 h after treatment administration, incremental doses of phenylephrine were infused (from 0.01 to 3 μg kg(-1) min(-1)), each dose being infused during 5 min.
RESULTS: Both fludrocortisone (P < 0.001) and hydrocortisone (P = 0.002) induced a significant decrease in pressor response to phenylephrine, their effects being additive (fludrocortisone × hydrocortisone interaction, P = 0.792). The two drugs did not induce any detectable cardiac effect.
CONCLUSIONS: Single administrations of fludrocortisone and hydrocortisone decreased the pressor response to phenylephrine in healthy volunteers with hypo-aldosteronism. These similar effects of hydrocortisone and fludrocortisone probably express a rapid non-genomic vasodilating effect of the two steroids in the context of acute volume loading.
© 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22703532      PMCID: PMC3579257          DOI: 10.1111/j.1365-2125.2012.04359.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  27 in total

1.  Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids.

Authors:  Florian P Limbourg; Zhihong Huang; Jean-Christophe Plumier; Tommaso Simoncini; Masayuki Fujioka; Jan Tuckermann; Günther Schütz; Michael A Moskowitz; James K Liao
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Lack of rapid aldosterone effects on forearm resistance vasculature in health.

Authors:  Prasad Gunaruwan; Matthias Schmitt; Justin Taylor; Leong Lee; Allan Struthers; Michael Frenneaux
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2002-06       Impact factor: 1.636

Review 3.  Nontranscriptional actions of the glucocorticoid receptor.

Authors:  Florian P Limbourg; James K Liao
Journal:  J Mol Med (Berl)       Date:  2003-03-14       Impact factor: 4.599

4.  Effect of hydrocortisone on phenylephrine--mean arterial pressure dose-response relationship in septic shock.

Authors:  E Bellissant; D Annane
Journal:  Clin Pharmacol Ther       Date:  2000-09       Impact factor: 6.875

5.  Biological and hemodynamic effects of low doses of fludrocortisone and hydrocortisone, alone or in combination, in healthy volunteers with hypoaldosteronism.

Authors:  B Laviolle; P Le Maguet; M-C Verdier; C Massart; E Donal; F Lainé; A Lavenu; D Pape; E Bellissant
Journal:  Clin Pharmacol Ther       Date:  2010-07-14       Impact factor: 6.875

6.  Aldosterone induces contraction of the resistance arteries in man.

Authors:  Paola Romagni; Fabio Rossi; Lara Guerrini; Chiara Quirini; Vittorio Santiemma
Journal:  Atherosclerosis       Date:  2003-02       Impact factor: 5.162

Review 7.  Nongenomic steroid action: controversies, questions, and answers.

Authors:  Ralf M Losel; Elisabeth Falkenstein; Martin Feuring; Armin Schultz; Hanns-Christian Tillmann; Karin Rossol-Haseroth; Martin Wehling
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

8.  Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure.

Authors:  D du Cheyron; A Lesage; C Daubin; M Ramakers; P Charbonneau
Journal:  Intensive Care Med       Date:  2003-08-28       Impact factor: 17.440

9.  Rapid nongenomic effects of aldosterone on human forearm vasculature.

Authors:  Bernhard M W Schmidt; Sebastian Oehmer; Christian Delles; Renate Bratke; Markus P Schneider; Arnfried Klingbeil; Erwin H Fleischmann; Roland E Schmieder
Journal:  Hypertension       Date:  2003-07-14       Impact factor: 10.190

10.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

View more
  2 in total

1.  Cardiac and vascular effects of low-dose steroids during the early phase of septic shock: An echocardiographic study.

Authors:  François Bagate; Alexandre Coppens; Paul Masi; Nicolas de Prost; Guillaume Carteaux; Keyvan Razazi; Armand Mekontso Dessap
Journal:  Front Cardiovasc Med       Date:  2022-09-26

2.  Combination of low-dose glucocorticosteroids and mineralocorticoids as adjunct therapy for adult patients with septic shock: A systematic review and meta-analysis of randomized trials and observational studies.

Authors:  Paraschos Archontakis Barakakis; Leonidas Palaiodimos; Derlis Fleitas Sosa; Linda Benes; Perminder Gulani; Daniel Fein
Journal:  Avicenna J Med       Date:  2019-10-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.